Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for CureVac
Company Monitoring Page for CureVac
latest headlines for company on cafepharma
CureVac initiates H5N1 avian influenza vaccine study
Clinical Trials Arena
Thu, 04/25/24 - 11:35 am
Tags:
CureVac
,
GSK
,
vaccines
,
H5N1
,
clinical trials
CureVac to cut costs in restructuring
BioPharma Dive
Wed, 04/24/24 - 09:14 pm
Tags:
CureVac
,
vaccines
,
layoffs
CureVac, chasing Moderna's mRNA flu vaccine, runs into the same B strain problems
Fierce Biotech
Thu, 04/4/24 - 11:24 am
Tags:
CureVac
,
Moderna Therapeutics
,
MRNA
,
flu vaccine
,
Flu
,
influenza B
,
vaccines
CureVac touts 'progress' as German court suspends infringement proceedings against BioNTech
Fierce Pharma
Thu, 09/28/23 - 11:40 pm
Tags:
CureVac
,
BioNTech
,
MRNA
,
patents
,
legal
CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South
Medical Marketing and Media
Fri, 05/19/23 - 10:22 am
Tags:
CureVac
,
COVID-19
,
vaccines
,
Pfizer
,
BioNTech
,
patents legal
Orbital shows 2023’s venture funding scene is far from stratospheric
EP Vantage
Fri, 05/19/23 - 10:06 am
Tags:
RNA
,
funding
,
venture capital
,
Altos Labs
,
CureVac
,
EQRx
,
Hasten Biopharmaceutic
,
Orbital Therapeutics
,
Sana Biotechnology
,
Suzhou Abogen Biosciences
,
TORL BioTherapeutics
GSK, CureVac initiate new Phase I/II trial of mRNA flu vaccine
Clinical Trials Arena
Mon, 05/8/23 - 11:27 pm
Tags:
GSK
,
CureVac
,
vaccines
,
MRNA
,
Flu
After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19 vaccines in older adults
Fierce Biotech
Mon, 01/30/23 - 10:33 am
Tags:
CureVac
,
clinical trials
,
MRNA
,
vaccines
,
COVID-19
,
Flu
,
GSK
CureVac's 'half-baked' COVID-flu data release questioned by analysts, but shares still rally 17%
Fierce Biotech
Sun, 01/8/23 - 10:05 pm
Tags:
CureVac
,
GSK
,
MRNA
,
vaccines
,
COVID-19
,
clinical trials
CureVac rethinks lead cancer program after posting PD-1 data, limiting future studies to mRNA vaccine combos
Fierce Biotech
Wed, 11/16/22 - 10:35 am
Tags:
CureVac
,
vaccines
,
CV8102
,
MRNA
,
cancer
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
Tags:
biopharma stocks
,
COVID-19
,
Eli Lilly
,
Bristol Myers Squibb
,
Merck
,
Daiichi Sankyo
,
Vertex Pharmaceuticals
,
Takeda
,
Neurocrine
,
Sarepta Therapeutics
,
Orion
,
Pfizer
,
GSK
,
Roche
,
Moderna Therapeutics
,
BeiGene
,
BioNTech
,
Novavax
,
CureVac
CureVac begins Phase I Omicron-targeting Covid-19 vaccine trial
Clinical Trials Arena
Fri, 08/19/22 - 10:31 am
Tags:
CureVac
,
clinical trials
,
MRNA
,
CV0501
,
boosters
,
COVID-19
Pfizer and BioNTech Push Hard on Omicron-Specific Vaccine While Fending Off Lawsuits
BioSpace
Wed, 07/27/22 - 10:47 am
Tags:
Pfizer
,
BioNTech
,
COVID-19
,
vaccines
,
boosters
,
patents
,
CureVac
Pfizer, BioNTech rebuff CureVac's 'groundless' patent infringement claims against COVID-19 shot Comirnaty
Fierce Pharma
Tue, 07/26/22 - 11:23 am
Tags:
Pfizer
,
BioNTech
,
COVID-19
,
CureVac
,
vaccines
,
patents
After its own vaccine flop, CureVac sues Pfizer partner BioNTech for patent infringement
Fierce Pharma
Tue, 07/5/22 - 10:46 am
Tags:
COVID-19
,
CureVac
,
BioNTech
,
patents
,
vaccines
CureVac increases focus on cancer vaccine development
Biopharma Reporter
Mon, 05/30/22 - 10:17 am
Tags:
CureVac
,
myNEO
,
vaccines
,
cancer
,
MRNA
With failed COVID shot still dragging on earnings, CureVac tries to turn page to next-gen mRNA tech
Fierce Biotech
Wed, 05/25/22 - 11:32 pm
Tags:
CureVac
,
COVID-19
,
vaccines
,
earnings
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Tags:
Pfizer
,
Biohaven
,
licensing
,
M&A
,
Aurinia
,
Bristol Myers Squibb
,
AbbVie
,
Alector
,
Arcus Biosciences
,
Biogen
,
Blueprint Medicines
,
CureVac
,
Gilead Sciences
,
GSK
,
Incyte
,
MorphoSys
,
Roche
,
Nestle
,
SAGE Therapeutics
,
Sarepta Therapeutics
,
Seres Therapeutics
,
Syndax
GlaxoSmithKline, CureVac and BioNTech clinch German pandemic preparedness contracts
Fierce Pharma
Mon, 04/11/22 - 10:33 am
Tags:
GSK
,
BioNTech
,
CureVac
,
Germany
,
pandemic
CureVac and GSK try again with COVID-19 vaccine
Pharmaforum
Thu, 03/31/22 - 10:21 am
Tags:
GSK
,
CureVac
,
vaccines
,
COVID-19
,
MRNA
Pages
1
2
3
4
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.